Cairo-Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) reported a growth of 37.6% in profits of the first quarter as compared to the same period in 2015, according to a bourse statement.
EIPICO’s net earnings increased to EGP 123.02 million ($13.9 million) in Q1-16, from EGP 89.41 million ($10.1 million) in Q1-15.
The standalone profits rose by 40.1% to EGP 116.62 million in Q1-16, from EGP 83.26 million in Q-15.
